News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Matthias Ocker: Novel small molecule MCL-1 inhibitor in vivo clearance and robust efficacy in solid and hematological tumor models
Photo from Matthias Ocker/X
Aug 31, 2024, 18:32

Matthias Ocker: Novel small molecule MCL-1 inhibitor in vivo clearance and robust efficacy in solid and hematological tumor models

Matthias Ocker, Head of Experimental Medicine at Tacalyx GmbH, shared on X:

“I’m excited to share our recent publication on a novel small molecule MCL-1 inhibitor now out in Nature Cancer. Thanks to an outstanding team to accomplish this.”

solid and hematological tumor

BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models

Authors: Ulrike Rauh, Guo Wei, Michael Serrano-Wu, Georgios Kosmidis, Stefan Kaulfuss, Franziska Siegel, Kai Thede, James McFarland, Christopher T. Lemke, Nicolas Werbeck, Katrin Nowak-Reppel, Sabine Pilari, Stephan Menz, Matthias Ocker, Weiqun Zhang, Kyle Davis, Guillaume Poncet-Montange, Jennifer Roth, Douglas Daniels, Virendar K. Kaushik, Brian Hubbard, Karl Ziegelbauer, Todd R. Golub

solid and hematological tumor

Source: Matthias Ocker/X

Brian Hubbard cancer Christopher T. Lemke Douglas Daniels Franziska Siegel Georgios Kosmidis Guillaume Poncet-Montange Guo Wei James McFarland Jennifer Roth Kai Thede Karl Ziegelbauer Katrin Nowak-Reppel Kyle Davis Matthias Ocker Michael Serrano-Wu Nature Cancer Nicolas Werbeck OncoDaily Oncology Sabine Pilari solid and hematological tumors Stefan Kaulfuss Stephan Menz Todd R Golub Ulrike Rauh Virendar K. Kaushik Weiqun Zhang
Special Coverage
Insight
Dec 22, 2024, 00:21
Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed
Blog
Dec 21, 2024, 22:40
50 Years of History, a Future to Write Together - AIEOP
Science
Dec 21, 2024, 22:37
Breaking Down the Impact of Ionizing Radiation on Cancer
Blog
Dec 21, 2024, 22:35
Santiago Viteri: Latest findings from the BR.31 trial presented at the 2024 ESMO Congress
Blog
Dec 21, 2024, 22:33
ABIM will develop two new assessment options focusing on breast cancer and hematologic neoplasms
Blog
Dec 21, 2024, 22:28
Adekemi Oyewusi: EDUCARE - Supporting the medical treatment and education of those impacted by childhood cancer
Blog
Dec 21, 2024, 22:26
Anas Younes: Transforming outcomes for people living with Blood Cancer
Blog
Dec 21, 2024, 19:42
Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials
Blog
Dec 21, 2024, 19:39
Kyaw Thein: Investigational Treatments for Thyroid and Head and Neck Cancers
Blog
Dec 21, 2024, 19:25
Hesham ElGhazaly: From an academic institution into a globally recognized hub for healthcare, research and innovation
Blog
Dec 21, 2024, 19:21
Douglas Flora: The 19 Words I’m Learning to Embrace as a Leader in 2025
Blog
Dec 21, 2024, 19:19
Registration and abstract submission open for the PTCOG63 - SIOP Europe